NCT07578311

Brief Summary

The primary objective of this randomized clinical trial is to evaluate and compare the effectiveness of two natural, herbal-based intracanal medications-Propolis and Green Tea Polyphenolics (EGCG)-against the conventional Calcium Hydroxide in reducing postoperative pain and the incidence of flare-ups during non-surgical root canal retreatment. Postoperative pain is a common complication in endodontics, particularly in retreatment cases where complex bacterial environments and procedural challenges increase the risk of discomfort and acute flare-ups. While Calcium Hydroxide is the traditional gold standard due to its antimicrobial properties, natural phytotherapeutics like Propolis and Green Tea are being investigated for their potent anti-inflammatory, antioxidant, and antibacterial benefits, which may offer superior biocompatibility and symptomatic relief. Forty patients requiring endodontic retreatment of single-rooted teeth will be randomly assigned to one of three groups: Group I (Control): Receives Calcium Hydroxide paste. Group II: Receives Propolis-based medication. Group III: Receives Green Tea Polyphenolic-based medication. The study follows a two-visit protocol. During the first visit, the previous root canal filling is removed, the canal is cleaned and shaped, and the assigned medication is placed. Postoperative pain will be assessed using a Visual Analog Scale (VAS) at 6, 12, 24, 48, 72 hours, and 7 days. Flare-up incidence (sudden severe pain or swelling) will also be monitored. In the second visit, the medication is removed, and the canal is permanently sealed using a bioceramic sealer and gutta-percha. The results will help determine if these herbal alternatives can provide a more comfortable treatment experience for patients undergoing root canal retreatment.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at below P25 for not_applicable postoperative-pain

Timeline
7mo left

Started Jul 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 5, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 11, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

July 1, 2026

Expected
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2027

Last Updated

May 11, 2026

Status Verified

May 1, 2026

Enrollment Period

6 months

First QC Date

May 5, 2026

Last Update Submit

May 5, 2026

Conditions

Keywords

postoperative painflare upintra-canal medicationcalcium hydroxidepropolisGreen Tea Polyphenolics

Outcome Measures

Primary Outcomes (2)

  • Postoperative pain

    Postoperative pain is to be assessed using visual analog scale (VAS), A scale from (0 to 10) where "0" means no pain and "10" means a severe pain that has never faced before. Patients will be contacted by phone at 6, 12, 24, 48, 72 hours and 7 days after the first visit to collect the postoperative pain data.

    6, 12, 24, 48, 72 hours and 7 days after the first visit to collect the postoperative pain data.

  • Flare-Up Incidence

    Flare-up is assessed through asking the patient to notify the investigator if any sudden severe pain or swelling takes place. This could require an unscheduled emergency visit or prescription of additional medication.

    Within 7 days post-treatment

Study Arms (3)

Calcium Hydroxide Group

ACTIVE COMPARATOR

Patients receiving conventional Calcium Hydroxide paste as an intracanal medication.

Drug: Calcium hydroxide

Propolis Group

EXPERIMENTAL

Patients receiving a Propolis-based herbal extract as an intracanal medication

Drug: Propolis Extract

Green Tea Group

EXPERIMENTAL

Patients receiving Green Tea Polyphenolics (EGCG) as an intracanal medication.

Drug: Green Tea Polyphenolics (EGCG)

Interventions

Following chemo-mechanical preparation and canal drying, Calcium Hydroxide paste is inserted into the root canal using a specialized syringe. The material is placed 0.5-1 mm from the apex to ensure complete filling without extrusion. It remains in the canal until the second visit for obturation.

Calcium Hydroxide Group

After cleaning, shaping, and drying the root canal, a Propolis-based natural resinous substance is used as an intracanal medication. The material is delivered via syringe to a depth of 0.5-1 mm from the apex. This herbal medicament is utilized for its antimicrobial and anti-inflammatory properties.

Propolis Group

Following the standardized cleaning protocol and canal drying, Green Tea Polyphenolics (EGCG) extract is inserted as an intracanal medication. The extract is placed 0.5-1 mm from the apex using a syringe. It serves as an herbal antioxidant and antimicrobial agent during the inter-appointment period.

Green Tea Group

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Failed previously performed endodontic treatment of single-rooted teeth.
  • Presence of a periapical lesion ranging from 1 mm to 2 mm in diameter.
  • Teeth with complete root formation.
  • Teeth without evidence of external or internal root resorption.

You may not qualify if:

  • Pregnant females.
  • Patients with uncontrolled systemic diseases.
  • Patients currently under antibiotic or analgesic administration.
  • Patients presenting with facial swelling.
  • Teeth not indicated for endodontic retreatment (e.g., poor oral hygiene, mobile teeth, or recessed teeth).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pain, PostoperativeSymptom Flare Up

Interventions

Calcium HydroxidePropolisepigallocatechin gallate

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsRecurrenceDisease Attributes

Intervention Hierarchy (Ancestors)

HydroxidesAlkaliesInorganic ChemicalsCalcium CompoundsAnionsIonsElectrolytesResins, PlantBiopolymersPolymersMacromolecular SubstancesPlant ExudatesBiological ProductsComplex Mixtures

Central Study Contacts

Abdullah Aiman Ghanemah

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: participants will be randomly assigned to one of three parallel groups. each group will receive a different intracanal medicament following non surgical root canal retreatment. post operative pain and flare up incidence will be assessed and compared between the three groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Postgraduate Student - Department of Endodontics

Study Record Dates

First Submitted

May 5, 2026

First Posted

May 11, 2026

Study Start (Estimated)

July 1, 2026

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

February 1, 2027

Last Updated

May 11, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Individual Participant Data (IPD) will not be shared due to privacy concerns and the limited scope of data use approved by the ethics committee. The study is designed for internal analysis only and does not include provisions for public data sharing